成人低骨量障碍常规骨学评估中的遗传学诊断
四个临床中心招募394例骨密度Z值<-2.0和/或病理性骨折的绝经前女性和55岁以下男性,排除继发原因后行靶向二代测序,20.8%携带罕见致病性变异,检出与阳性家族史、外周骨折>2次及高正常BMI相关,与年龄、椎体骨折、骨密度或生化指标无关。
要点
- 20.8%的成人低骨量障碍患者携带罕见致病性变异,9.7%携带意义不明变异。
- 检出致病性变异的可能性与骨质疏松阳性家族史、外周骨折>2次及高正常BMI相关。
- 突变频率与年龄、椎体骨折、骨密度或生化参数无关。
核心结论
- 单基因成人低骨量障碍的重叠谱可通过基因检测容易地区分,所提出的临床标准有助于最大化诊断率。
研究设计与样本
- 四个临床中心广泛招募394例无亲缘关系的绝经前女性和55岁以下男性,骨密度Z值<-2.0和/或病理性骨折,排除继发原因或单基因低骨量障碍明确临床/生化标志后,全部行靶向二代测序。
主要发现
- 20.8%的参与者携带已知导致成骨不全(COL1A1、COL1A2)、低磷酸酯酶症(ALPL)和早发性骨质疏松(LRP5、PLS3、WNT1)基因的罕见致病性变异。
- 此外鉴定出ENPP1、LMNA、NOTCH2和ZNF469中的罕见致病性变异。
- 3例为常染色体隐性、75例为常染色体显性、4例为X连锁疾病。
- 9.7%的参与者携带意义不明变异。
- 回归分析显示检出致病性变异的可能性与骨质疏松阳性家族史、外周骨折>2次及高正常体重指数相关,突变频率与年龄、现患椎体骨折、骨密度或生化参数无关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Many different inherited and acquired conditions can result in premature bone fragility/low bone mass disorders (LBMDs). OBJECTIVE: We aimed to elucidate the impact of genetic testing on differential diagnosis of adult LBMDs and at defining clinical criteria for predicting monogenic forms. METHODS: Four clinical centers broadly recruited a cohort of 394 unrelated adult women before menopause and men younger than 55 years with a bone mineral density (BMD) Z-score < -2.0 and/or pathological fractures. After exclusion of secondary causes or unequivocal clinical/biochemical hallmarks of monogenic LBMDs, all participants were genotyped by targeted next-generation sequencing. RESULTS: In total, 20.8% of the participants carried rare disease-causing variants (DCVs) in genes known to cause osteogenesis imperfecta (COL1A1, COL1A2), hypophosphatasia (ALPL), and early-onset osteoporosis (LRP5, PLS3, and WNT1). In addition, we identified rare DCVs in ENPP1, LMNA, NOTCH2, and ZNF469. Three individuals had autosomal recessive, 75 autosomal dominant, and 4 X-linked disorders. A total of 9.7% of the participants harbored variants of unknown significance. A regression analysis revealed that the likelihood of detecting a DCV correlated with a positive family history of osteoporosis, peripheral fractures (> 2), and a high normal body mass index (BMI). In contrast, mutation frequencies did not correlate with age, prevalent vertebral fractures, BMD, or biochemical parameters. In individuals without monogenic disease-causing rare variants, common variants predisposing for low BMD (eg, in LRP5) were overrepresented. CONCLUSION: The overlapping spectra of monogenic adult LBMD can be easily disentangled by genetic testing and the proposed clinical criteria can help to maximize the diagnostic yield.
引用
- Oheim R, Tsourdi E, Seefried L, et al. Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders. J Clin Endocrinol Metab. 2022. PMID: 35276006. doi:10.1210/clinem/dgac147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。